Biomarker tests and technologies for the total support of systemic lupus erythematosus
 

Diagnostic & digital technologies to bridge the care gap for clinicians and Lupus Warriors

 
 
 
progentec-website-header-woman-flip.jpg
 

Lupus is a chronic autoimmune condition with devastating effects, predominantly on women between the ages of 15-45.

Inability to diagnose the disease early, understand its progression, and predict periodic flare-ups results in irreversible organ damage and death. Progentec's biomarker-based platform offers multiple tests to manage various facets of the disease ranging from diagnosis to disease tracking and flare prediction - these come with a suite of digital health solutions. Progentec is thus uniquely positioned to bring about novel ways to engage patients and other stakeholders and deliver better clinical and economic outcomes.

Lupus Warriors

 
 
89percent white.png
 
 

WANT TO BETTER UNDERSTAND HOW THEIR DISEASE CHANGES OVER TIME


 
 
77percentwhite.png
 

DON’T KNOW HOW THEIR TREATMENT TEAM MEASURES DISEASE ACTIVITY

 
 
 

"We've made tremendous progress in developing a tool for the identification of lupus flare-ups before they occur."

Mohan Purushothaman, CEO

 
 
color-splash-dark.jpg
 


Systemic Lupus Erythematosus (SLE) is a disease of the immune system affecting an estimated 1.5 million Americans. The Progentec TOTAL FEEDBACK research team is investigating the clues present in the bloodstream before a lupus flare even occurs.